Stay updated on Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a study on psilocybin for treatment-resistant depression, while retaining some references to the study's open label design and revision history.SummaryDifference29%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check111 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial page.